Trials / Completed
CompletedNCT05641311
Pharmacokinetic Study of Oral ALXN1840 in Japanese and Non-Japanese Adult Healthy Participants
An Open-Label, Two-Single Dose, Two-Period, Parallel Group Study to Assess the Pharmacokinetics and Safety of ALXN1840 in Healthy Adult Japanese and Non-Japanese Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- Alexion Pharmaceuticals, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The main purpose of the study is to confirm how long ALXN1840 stays in the body of Japanese and non-Japanese healthy participants (that is, pharmacokinetic \[PK\] profile).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ALXN1840 | Tablet for oral use. |
Timeline
- Start date
- 2019-02-20
- Primary completion
- 2019-05-02
- Completion
- 2019-05-02
- First posted
- 2022-12-07
- Last updated
- 2023-11-07
- Results posted
- 2023-11-07
Locations
1 site across 1 country: United Kingdom
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT05641311. Inclusion in this directory is not an endorsement.